CannabisNewsBreaks – InMed Pharmaceuticals Inc. (TSX: IN) (OTCQX: IMLFF) Adds Strategic Appointment to Scientific Advisory Board
Cannabinoid-based biopharmaceutical company InMed Pharmaceuticals (TSX: IN) (OTCQX: IMLFF) today announced its addition of Dr. Steven M. Dinh to its Scientific Advisory Board. Per the update, Dr. Dinh brings more than 30 years of pharmaceutical and biotech executive leadership, as well as proven success in developing and commercializing dermal pharmaceutical products by applying innovative drug delivery technologies. Over 22 issued U.S. patents, 44 published patent applications, 6 NDA approvals and the successful commercialization of 9 products to serve the unmet needs of patients are a result of Dr. Dinh’s accomplishments and innovations in pharmaceutical product development and drug delivery technology.…

















